Di Nuzzo Private Wealth, Inc. Xencor Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $634 Million
- Q3 2024
Shares
3 transactions
Others Institutions Holding XNCR
# of Institutions
200Shares Held
63.2MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$257 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$211 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$162 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$124 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$91.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.38B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...